Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

statnews.com

STAT

Get the latest updates from STAT directly as they happen.

Follow now 269 followers

Latest posts

Last updated about 21 hours ago

STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?

about 21 hours ago

A newly acquired Novartis drug successfully lowered signs of inflammation in a...

Juul gets OK to sell updated vaping device with age-gating technology

1 day ago

WASHINGTON — Vaping company Juul Labs on Friday received federal permission to...

Opinion: The unintended consequences of the Lindsay Clancy case

1 day ago

Much of the focus on the Lindsay Clancy case has been on...

STAT+: Up and down the ladder: The latest comings and goings

1 day ago

Hired someone new and exciting? Promoted a rising star? Finally solved that...

STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

1 day ago

Want to stay on top of the science and politics driving biotech...

At a federal autism advisory committee meeting, members double down on long-debunked theories

1 day ago

Get your daily dose of health and medicine every weekday with STAT’s...

STAT+: Cytokinetics details trial win for what could be its next approval

2 days ago

It took Cytokinetics 27 years to win its first regulatory approval. The...

STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs

2 days ago

AstraZeneca on Friday detailed the surprise failure of a closely watched heart...

Opinion: We quit the CDC last year. The problems we protested remain

2 days ago

One year ago, we jointly submitted our resignations from the Centers for...

STAT+: Vaccines take center stage at federal autism advisory committee

2 days ago

Vaccines took center stage at the federal autism advisory committee meeting Thursday...